Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_assertion description "[Variations in solute carrier family 6A, member 3 (SLC6A3/DAT1), the human gene encoding DAT, have been implicated in attention deficit hyperactivity and bipolar disorders, and DAT is a prominent site of action for drugs such as amphetamines and cocaine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_assertion evidence source_evidence_literature NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_assertion SIO_000772 19504720 NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_assertion wasDerivedFrom befree-20150227 NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_assertion wasGeneratedBy ECO_0000203 NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP698246.RAJUvzQCdnQf9eDvg8PT-xYUICXlIpDEF19FU_jdf0wzQ130_provenance.